FINISHED DOSAGE FORMULATIONS

With 20 years of experience in the production of high quality drugs, we have launched our own products in the areas of antiretroviral, osteoporosis and other specialized therapies.

read more

APIs

Our active pharmaceutical ingredients comply with national and international quality standards and meet all pharmaceutical industry requirements.

read more

RESEARCH & DEVELOPMENT

Blanver has continuously invested in innovation, research & development exploring creative solutions to meet the needs of the market either in ingredients or in finished dosage formulations.

read more

Blanver in the Press

30/07/2018 - Exame

Genérico ajudará governo brasileiro a atingir meta de erradicação da Hepatite C até 2030

CHECK NEWS CHECK NEWS
27/07/2018 - Guia da Farmácia

ANVISA aprova genérico de prevenção do HIV

CHECK NEWS CHECK NEWS
27/07/2018 - Abifina

Genérico ajudará governo brasileiro a atingir meta de erradicação da Hepatite C até 2030

CHECK NEWS CHECK NEWS
View all